Risk factors and outcomes associated with new-onset atrial fibrillation during acute respiratory distress syndrome

Journal of Critical Care

Volumn 30, Issue 5, 2015, Pages 994-997

  Ambrus, Daniel B ^a,b   Benjamin, Emelia J ^b   Bajwa, Ednan K ^c   Hibbert, Kathryn A ^c   Walkey, Allan J ^b  

^a UMASS MEMORIAL MEDICAL CENTER   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Acute respiratory distress syndrome; Atrial fibrillation; Epinephrine; Interleukins; Mechanism; Mortality; Troponin

Indexed keywords

ADRENALIN; BICARBONATE; BILIRUBIN; CREATININE; DOPAMINE; GLUCOSE; HEMOGLOBIN; INTERLEUKIN 6; INTERLEUKIN 8; MAGNESIUM; NORADRENALIN; POTASSIUM; SALBUTAMOL; SODIUM; TROPONIN I; BIOLOGICAL MARKER; BRONCHODILATING AGENT; IL6 PROTEIN, HUMAN; IL8 PROTEIN, HUMAN;

ADRENALIN BLOOD LEVEL; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; APACHE; ARTICLE; BICARBONATE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CASE CONTROL STUDY; CENTRAL VENOUS PRESSURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG USE; FEMALE; GLUCOSE BLOOD LEVEL; HEART RATE; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY (TOPIC); NEW-ONSET ATRIAL FIBRILLATION; OUTCOME ASSESSMENT; PATIENT RISK; POTASSIUM BLOOD LEVEL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SODIUM BLOOD LEVEL; AGED; ATRIAL FIBRILLATION; BLOOD; COMPLICATION; HOSPITAL MORTALITY; ODDS RATIO; PATHOPHYSIOLOGY; PROGNOSIS; RESPIRATORY DISTRESS SYNDROME, ADULT;

AGED; ALBUTEROL; ATRIAL FIBRILLATION; BIOMARKERS; BRONCHODILATOR AGENTS; FEMALE; HOSPITAL MORTALITY; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MIDDLE AGED; ODDS RATIO; PROGNOSIS; PROSPECTIVE STUDIES; RESPIRATORY DISTRESS SYNDROME, ADULT; RISK FACTORS;

EID: 84941314657     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2015.06.003     Document Type: Article

References (24)

1. Annane D., Sebille V., Duboc D., Le Heuzey J.Y., Sadoul N., Bouvier E., et al. Incidence and prognosis of sustained arrhythmias in critically ill patients. Am J Respir Crit Care Med 2008, 178:20-25.
2. Walkey A.J., Greiner M.A., Heckbert S.R., Jensen P.N., Piccini J.P., Sinner M.F., et al. Atrial fibrillation among Medicare beneficiaries hospitalized with sepsis: incidence and risk factors. Am Heart J 2013, 165:949-955.e3.
3. Walkey A.J., Wiener R.S., Ghobrial J.M., Curtis L.H., Benjamin E.J. Incident stroke and mortality associated with new-onset atrial fibrillation in patients hospitalized with severe sepsis. JAMA 2011, 306:2248-2254.
4. Walkey A.J., Hammill B.G., Curtis L.H., Benjamin E.J. Long term outcomes following development of new-onset atrial fibrillation during sepsis. Chest 2014, 146:1187-1195.
5. Kanji S., Williamson D.R., Yghchi B.M., Albert M., McIntyre L. Epidemiology and management of atrial fibrillation in medical and noncardiac surgical adult intensive care unit patients. J Crit Care 2012, 326.e1-326.e8.
6. Kanji S., Stewart R., Fergusson D.A., McIntyre L., Turgeon A.F., Hébert P.C. Treatment of new-onset atrial fibrillation in noncardiac intensive care unit patients: a systematic review of randomized controlled trials. Crit Care Med 2008, 36:1620-1624.
7. Salman S., Bajwa A., Gajic O., Afessa B. Paroxysmal atrial fibrillation in critically ill patients with sepsis. J Intensive Care Med 2008, 23:178-183.
8. Christian S.A., Schorr C., Ferchau L., Jarbrink M.E., Parrillo J.E., Gerber D.R. Clinical characteristics and outcomes of septic patients with new-onset atrial fibrillation. J Crit Care 2008, 23:532-536.
9. Meierhenrich R., Steinhilber E., Eggermann C., Weiss M., Voglic S., Bogelein D., et al. Incidence and prognostic impact of new-onset atrial fibrillation in patients with septic shock: a prospective observational study. Crit Care 2010, 14:R108.
10. De Backer D., Biston P., Devriendt J., Madl C., Chochrad D., Aldecoa C., et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 2010, 362:779-789.
11. Chamberlain A.M., Agarwal S.K., Folsom A.R., Soliman E.Z., Chambless L.E., Crow R., et al. A clinical risk score for atrial fibrillation in a biracial prospective cohort (from the atherosclerosis risk in communities [ARIC] study). Am J Cardiol 2011, 107:85-91.
12. Schnabel R.B., Sullivan L.M., Levy D., Pencina M.J., Massaro J.M., D'Agostino R.B.S., et al. Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet 2009, 373:739-745.
13. Fuster V., Ryden L.E., Cannom D.S., Crijns H.J., Curtis A.B., Ellenbogen K.A., et al. American College of Cardiology Foundation/American Heart Association Task Force. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011, 123:e269-e367.
14. National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, Matthay M.A., Brower R.G., Carson S., Douglas I.S., Eisner M., et al. Randomized, placebo-controlled clinical trial of an aerosolized beta(2)-agonist for treatment of acute lung injury. Am J Respir Crit Care Med 2011, 184:561-568.
15. Knaus W.A., Wagner D.P., Draper E.A., Zimmerman J.E., Bergner M., Bastos P.G., et al. The APACHE III prognostic system. risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991, 100:1619-1636.
16. De Backer D., Aldecoa C., Njimi H., Vincent J.L. Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis. Crit Care Med 2012, 40:725-730.
17. Makrygiannis S.S., Margariti A., Rizikou D., Lampakis M., Vangelis S., Ampartzidou O.S., et al. Incidence and predictors of new-onset atrial fibrillation in noncardiac intensive care unit patients. J Crit Care 2014, 697.e1-697.e5.
18. Ren D. Sodium leak channels in neuronal excitability and rhythmic behaviors. Neuron 2011, 72:899-911.
19. Ruan Y., Liu N., Priori S.G. Sodium channel mutations and arrhythmias. Nat Rev Cardiol 2009, 6:337-348.
20. Antzelevitch C., Burashnikov A. Atrial-selective sodium channel block as a novel strategy for the management of atrial fibrillation. Ann N Y Acad Sci 2010, 1188:78-86.
21. Walsh S.R., Oates J.E., Anderson J.A., Blair S.D., Makin C.A., Walsh C.J. Postoperative arrhythmias in colorectal surgical patients: incidence and clinical correlates. Colorectal Dis 2006, 8:212-216.
22. Glance L.G., Dick A.W., Osler T.M., Mukamel D.B. Accuracy of hospital report cards based on administrative data. Health Serv Res 2006, 41:1413-1437.
23. Jorfida M., Antolini M., Cerrato E., Caprioli M.G., Castagno D., Garrone P., et al. Cryptogenic ischemic stroke an prevalence of asymptomatic atrial fibrillation: a prospective study. J Cardiovasc Med (Hagerstown) 2014, [Epub ahead of print].
24. Ho A.M., Dion P.W., Ng C.S., Karmakar M.K. Understanding immortal time bias in observational cohort studies. Anaesthesia 2013, 68:126-130.